We report the hemolysis properties of silver and silver oxide nanoparticles (NPs) prepared by chemical and green-synthesis methods. The prepared silver and silver oxide NPs were analyzed using UV–vis spectroscopy to confirm their formation by characterizing their surface plasmon resonance (SPR) and absorption band peaks respectively. The Fourier transmission infrared (FTIR) spectra of the materials showed the characteristic functional groups corresponding to the molecules present in leaf extracts, which is proposed to be acted as reducing and capping agents that are also found on the surface of silver and silver oxide nanoparticles that synthesized via green-synthesis method. Zeta potential analysis revealed the surface charge and stability of the prepared NPs. HRTEM images showed almost spherical shape nanoparticles with an average size of 15.2 and 31.5 nm for wet chemical synthesized silver and silver oxide nanoparticles respectively. In the case of green synthesized silver and silver oxide nanoparticles, it was observed to be 19.4 and 30.4 nm respectively. The order of hemolysis efficacy of the materials is found to be as follows: chemically synthesized Ag 2 O> chemically synthesized Ag NPs followed by green-synthesized Ag 2 O and green-synthesized Ag NPs which showed almost similar hemolysis with respect to concentration. The relatively stable nature of the silver NPs could be attributed to their lower hemolysis efficacy, while the increased lysis properties of silver oxide could be attributed due to reductive/oxidative processes that give rise to the hemolysis through interfacial charge interactions with RBCs.
No takes yet. Share an insight, caveat, or question.
S. Balakumar (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: